Table II.
Correlation between galectin-3 expression and clinicopathological characteristics of the patients with non-small cell lung cancer.
| Patient characteristics | n | High expression of galectin-3 n (%) | P-value |
|---|---|---|---|
| Total | 57 | 20 (35.1) | |
| Sex | |||
| Male | 28 | 11 (39.3) | 0.946 |
| Female | 29 | 9 (31.0) | |
| Smoking status | |||
| Never | 31 | 11 (35.5) | 0.551 |
| Current/former | 26 | 9 (34.6) | |
| T stage | |||
| T1a | 4 | 3 (75.0) | 0.548 |
| T1b | 24 | 8 (33.3) | |
| T1c | 18 | 5 (27.8) | |
| T2a | 6 | 2 (33.3) | |
| T2b | 5 | 2 (40.0) | |
| Histological subtype | |||
| Lepidic | 16 | 4 (25.0) | 0.201 |
| Papillary | 26 | 8 (30.8) | |
| Acinar | 11 | 6 (54.5) | |
| Solid | 3 | 1 (33.3) | |
| Micropapillary | 1 | 1 (100.0) | |
| Microvessel invasion | |||
| Absent | 32 | 6 (18.8) | 0.004 |
| Present | 25 | 14 (56.0) | |
| Tumor recurrence | |||
| No | 44 | 9 (20.5) | <0.001 |
| Yes | 13 | 11 (84.6) | |
P-values were calculated using the Mann-Whitney U test. Bold print indicates significance.